Zhitong Financial APP News, Hanyu Pharmaceutical (300199.SZ) issued a notice that recently, the company's oxytocin raw materials have received a CEP (European Pharmacopoeia applicability Certification) certificate issued by the European Drug quality Administration ("EDQM").
It is reported that oxytocin is a cyclic nine-peptide compound composed of nine amino acid residues, which has a hormone structure produced by the posterior pituitary, which can stimulate uterine contraction and lactation in receptive mammals. The preparation is clinically used for induced labor, induced labor, postpartum and miscarriage due to uterine weakness or poor contraction caused by uterine bleeding and to understand placental reserve function (oxytocin provocation test).
The announcement said that the oxytocin (API) obtained the CEP certificate issued by the European Drug quality Administration, which opened up access channels for the company's oxytocin (API) to enter the EU market, had a positive impact on the company's API overseas market, helped to enhance the company's international brand influence, and the company will actively promote the listing and sale of the drug.